| Safety of outpatient treatment in acute pulmonary embolism PMG Erkens, E Gandara, P Wells, AYH SHEN, G Bose, G Le Gal, ... Journal of Thrombosis and Haemostasis 8 (11), 2412-2417, 2010 | 115 | 2010 |
| Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment? PMG Erkens, E Gandara, PS Wells, AYH Shen, G Bose, G Le Gal, ... Thrombosis research 129 (6), 710-714, 2012 | 65 | 2012 |
| Serum neurofilament light in MS: The first true blood-based biomarker? S Thebault, G Bose, R Booth, MS Freedman Multiple Sclerosis Journal 28 (10), 1491-1497, 2022 | 40 | 2022 |
| Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review G Bose, J Graveline, V Yogendrakumar, R Shorr, DA Fergusson, G Le Gal, ... BMJ open 11 (2), e040212, 2021 | 39 | 2021 |
| A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis G Bose, C Rush, HL Atkins, MS Freedman Multiple Sclerosis and Related Disorders 52, 102945, 2021 | 29 | 2021 |
| Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis S Thebault, H Lee, G Bose, D Tessier, M Abdoli, M Bowman, J Berard, ... Annals of Clinical and Translational Neurology 7 (5), 767-775, 2020 | 27 | 2020 |
| Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment G Bose, MS Freedman Multiple Sclerosis Journal 26 (5), 540-547, 2020 | 27 | 2020 |
| Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis G Bose, HL Atkins, M Bowman, MS Freedman Multiple Sclerosis Journal 25 (13), 1764-1772, 2019 | 27 | 2019 |
| Outcomes of saddle pulmonary embolism: a nested case‐control study E Gandara, G Bose, P Erkens, M Rodgers, M Carrier, P Wells Journal of Thrombosis and Haemostasis 9 (4), 867-869, 2011 | 20 | 2011 |
| Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol G Bose, J Graveline, V Yogendrakumar, D Fergusson, D Dowlatshahi Systematic reviews 8, 1-4, 2019 | 19 | 2019 |
| Early predictors of clinical and MRI outcomes using least absolute shrinkage and selection operator (LASSO) in multiple sclerosis G Bose, BC Healy, HA Lokhande, MG Sotiropoulos, M Polgar‐Turcsanyi, ... Annals of neurology 92 (1), 87-96, 2022 | 15 | 2022 |
| Outcomes of patients requiring insertion of an inferior vena cava filter: a retrospective observational study LD Duffett, E Gándara, A Cheung, G Bose, AJ Forster, PS Wells Blood Coagulation & Fibrinolysis 25 (3), 266-271, 2014 | 15 | 2014 |
| Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes KB Holroyd, BC Healy, S Conway, M Houtchens, R Bakshi, ... Multiple sclerosis and related disorders 67, 104079, 2022 | 12 | 2022 |
| Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a systematic review N Molazadeh, G Bose, I Lotan, M Levy Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (4 …, 2022 | 12 | 2022 |
| Reactivation of SARS-CoV-2 after rituximab in a patient with multiple sclerosis G Bose, K Galetta Multiple sclerosis and related disorders 52, 102922, 2021 | 12 | 2021 |
| Autologous hematopoietic stem cell transplantation for multiple sclerosis: a current perspective G Bose, S Thebault, CA Rush, HL Atkins, MS Freedman Multiple Sclerosis Journal 27 (2), 167-173, 2021 | 12 | 2021 |
| Recent advances and remaining questions of autologous hematopoietic stem cell transplantation in multiple sclerosis G Bose, MS Freedman Journal of the Neurological Sciences 421, 117324, 2021 | 11 | 2021 |
| Does resetting the immune system fix multiple sclerosis? G Bose, SDX Thebault, HL Atkins, MS Freedman Canadian Journal of Neurological Sciences 47 (1), 1-10, 2020 | 10 | 2020 |
| Predicting Venous Thromboembolism Recurrence Risk in Patients with Cancer: A Validation Study ML Louzada, G Bose, A Cheung, BH Chin-Yee, S Wells, PS Wells Blood 120 (21), 394, 2012 | 10 | 2012 |
| Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes G Bose, BC Healy, S Saxena, F Saleh, A Paul, C Barro, HA Lokhande, ... Multiple Sclerosis and Related Disorders 74, 104695, 2023 | 5 | 2023 |
